Frontiers in Bioscience-LandmarkBiochemistryPeer-reviewed journal article
ApoA-I dissociated from human HDL retains its acceptor properties in ABCA1-mediated cholesterol efflux from RAW 264.7 macrophages in coronary artery disease
Veronika B. BaserovaiD, Mikhail Aleksandrovich PopoviD, Alexander D. DergunoviD
Abstract
BackgroundThe significance of cholesterol efflux as a predictor of coronary artery disease (CAD) remains controversial. The primary route for intracellular cholesterol export via the ABCA1 transporter involves the acceptance of cholesterol by lipid-free apolipoprotein A-I and high-density lipoproteins (HDL). A separate estimate of the efficiencies of two reactions is thus required. MethodsHDL from plasma of 63 control and 76 CAD male patients was obtained by PEG precipitation of apoB-containing lipoproteins and denatured by 4.25 M urea at the transition midpoint. We measured apoA-I dissociation concomitant with HDL denaturation, the expression of 65 preselected genes by real-time PCR, and the efficiency of ABCA1-mediated cholesterol efflux from RAW 264.7 macrophages to dissociated lipid-free apoA-I. The dissociation parameter D was calculated from the accumulation of apoA-I with pre{beta}-mobility at HDL separation by agarose gel electrophoresis followed by immunodetection. ResultsThe phospholipid:apoA-I and cholesterol: apoA-I ratios for CAD patients were consistently higher than those for control patients in a whole range of plasma HDL-cholesterol levels. ApoA-I partitioned 1.5-fold higher into the water phase for HDL from CAD patients relative to controls. For CAD patients, the dissociation parameter D was inversely correlated with phospholipid and cholesterol levels and the cholesterol:apoA-I ratio in HDL. For control patients, the D parameter was positively correlated with CETP and ABCA1 gene expression levels. For CAD patients, the D parameter was negatively correlated with CUBN and ALB gene expression levels that may be associated with the increased catabolism of lipid-free apoA-I. The Vm and Km values showed that apoA-I functionality in ABCA1-mediated cholesterol efflux from RAW 264.7 macrophages to lipid-free apoA-I generated at urea-induced HDL denaturation was similar for HDL from both groups. ConclusionsThe enrichment of HDL with cholesterol, with the concomitant increase of competition between apoA-I and cholesterol for the binding to phospholipid molecules adjacent to apoA-I, could be involved in the increased apolipoprotein dissociation from HDL in CAD. The obtained estimates for the ABCA1-mediated cholesterol efflux to lipid-free apoA-I may be the prerequisite for the detailed study of cholesterol efflux kinetics with two apoA-I forms that could allow to be described them as CAD predictors.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 0th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ABCA1 and apoA-I dependent 12-hydroxyeicosatetraenoic acid efflux regulates macrophage inflammatory signaling
Brian A. Harsch, Kamil Borkowski, … Gregory C. Shearer·bioRxiv·Jul 11, 2024
- Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Preserves HDL Atheroprotective Functions
J. Huang, P. G. Yancey, … M. F. Linton·bioRxiv·Jan 23, 2019
- Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
J. O. Lagerstedt, O. Nilsson, … R. Del Giudice·bioRxiv·Apr 8, 2020
- Monocyte and Macrophage Subtypes as Paired Cell Biomarkers for Coronary Artery Disease
K. A. Arnold, J. E. Blair, … F. Alenghat·bioRxiv·May 16, 2018
- Aegeline and Atorvastatin Synergistically Attenuate oxLDL-Induced Inflammation and Intracellular Cholesterol Accumulation in THP-1 Macrophages
Abinayaa Rajkumar, Cathline Mary Ramesh, … Periandavan Kalaiselvi·bioRxiv·Aug 21, 2026
- Acceleration of HDL-mediated cellular cholesterol efflux alleviates periodontitis
J.-h. Ryu, T.-T. Tran, … J.-T. Koh·bioRxiv·Jan 18, 2024